Associate Professor, Dentistry and Oral Surgery Cornell University Ithaca, New York
Depending on the stage of the disease, the treatment of choice for most oral tumors in dogs is wide-margin surgical excision, which frequently results in patient disfigurement and dysfunction. Recent studies have started to elucidate molecular vulnerabilities that can be targeted using non-surgical approaches. This lecture discusses canine oral squamous cell carcinoma and how targeted therapies can complement traditional treatment approaches to help minimize morbidity while enhancing outcomes.
